Seroatlas · Human Serome Atlas

CD80

T-lymphocyte activation antigen CD80

Also known as: B7-1, B7.1, CD28LG, CD28LG1, CD80_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P33681
Gene
CD80
Ensembl
ENSG00000121594
Chromosome
3
Canonical length
288 aa
Protein class
CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins
Secretome location
Intracellular and membrane
Quaternary structure
Homodimer

OverviewNCBI Gene

The protein encoded by this gene is a membrane receptor that is activated by the binding of CD28 or CTLA-4. The activated protein induces T-cell proliferation and cytokine production. This protein can act as a receptor for adenovirus subgroup B and may play a role in lupus neuropathy. [provided by RefSeq, Aug 2011]

Canonical amino-acid sequenceUniProt

288 residues, UniProt reviewed canonical sequence.

>P33681|CD80
     1  MGHTRRQGTS PSKCPYLNFF QLLVLAGLSH FCSGVIHVTK EVKEVATLSC GHNVSVEELA
    61  QTRIYWQKEK KMVLTMMSGD MNIWPEYKNR TIFDITNNLS IVILALRPSD EGTYECVVLK
   121  YEKDAFKREH LAEVTLSVKA DFPTPSISDF EIPTSNIRRI ICSTSGGFPE PHLSWLENGE
   181  ELNAINTTVS QDPETELYAV SSKLDFNMTT NHSFMCLIKY GHLRVNQTFN WNTTKQEHFP
   241  DNLLPSWAIT LISVNGIFVI CCLTYCFAPR CRERRRNERL RRESVRPV

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against CD80 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Cell surface
Secreted
No
Transmembrane segments
1
Mean surface accessibility (rSASA)
0.39
Highest tissue expression
6.4 nTPM

Expression across tissuesHPA

Tissue

  • tonsil: 6.4 nTPM
  • lymph node: 5.2 nTPM
  • appendix: 5 nTPM
  • spleen: 3.2 nTPM
  • lung: 2.8 nTPM
  • thymus: 2.4 nTPM

Single-cell type

  • cdc: 31 nCPM
  • macrophages: 23 nCPM
  • b-cells: 22 nCPM
  • kupffer cells: 18 nCPM
  • monocytes: 7.9 nCPM
  • megakaryocytes: 6.2 nCPM

Immune cell

  • memory B-cell: 1.4 nTPM
  • T-reg: 1.3 nTPM
  • non-classical monocyte: 0.4 nTPM
  • intermediate monocyte: 0.2 nTPM
  • naive B-cell: 0.2 nTPM
  • memory CD4 T-cell: 0.1 nTPM

Brain region

  • choroid plexus: 1.7 nTPM
  • thalamus: 1.4 nTPM
  • medulla oblongata: 1.1 nTPM
  • spinal cord: 1.1 nTPM
  • white matter: 1.1 nTPM
  • cerebral cortex: 0.9 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about CD80.

Disease | AutoantibodyPubMed

Conditions in which antibodies against CD80 are reported. Each links to that disease's full target list.

ReferencesPubMed · IEDB

Publications for CD80 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.

Reference: AutoantibodyPubMed

11 publications

Show 6 more

Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.9
gnomAD pLI
0.01
gnomAD missense Z
0.75
DepMap mean gene effect
0.05
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of CD80 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads CD80 as an antibody target. Whether an autoantibody or antibody against CD80 could matter depends on whether native CD80 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

CD80 is annotated at the cell surface, where native CD80 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.

Annotation status

The present source text does not explicitly label CD80 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/CD80. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...